These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32473648)

  • 1. Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome.
    Su G; Gao MX; Shi GL; Dai XX; Yao WF; Zhang T; Zhuang SW
    Cardiovasc Diabetol; 2020 May; 19(1):71. PubMed ID: 32473648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Isoprostanes-Related Oxidative Stress with Vulnerability of Culprit Lesions in Diabetic Patients with Acute Coronary Syndrome.
    Su G; Zhang T; Yang HX; Dai WL; Wang T; Tian L; Mi SH
    Int Heart J; 2019 Mar; 60(2):271-279. PubMed ID: 30745536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.
    Ouchi S; Shimada K; Miyazaki T; Takahashi S; Sugita Y; Shimizu M; Murata A; Kadoguchi T; Kato T; Aikawa T; Suda S; Sai E; Hiki M; Iwata H; Kasai T; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2017 Nov; 16(1):151. PubMed ID: 29157245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of serum 1,5-anhydro-D-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study.
    Wada H; Dohi T; Miyauchi K; Takahashi N; Endo H; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
    Cardiovasc Diabetol; 2019 Jun; 18(1):69. PubMed ID: 31159826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 8-iso-prostaglandin F
    Su G; Wang T; Zhang T; Yang HX; Yu SS; Dai WL; Mi SH
    Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():11-17. PubMed ID: 30553398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk.
    Fujiwara T; Yoshida M; Yamada H; Tsukui T; Nakamura T; Sakakura K; Wada H; Arao K; Katayama T; Funayama H; Sugawara Y; Mitsuhashi T; Kakei M; Momomura S; Ako J
    Heart Vessels; 2015 Jul; 30(4):469-76. PubMed ID: 24691699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of coronary culprit-plaque characteristics with duration of diabetes mellitus in acute myocardial infarction: an intravascular optical coherence tomography study.
    Sheng Z; Zhou P; Liu C; Li J; Chen R; Zhou J; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2019 Oct; 18(1):136. PubMed ID: 31629406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between glycemic control and coronary artery disease severity, prevalence and plaque characteristics by computed tomography coronary angiography in asymptomatic type 2 diabetic patients.
    Tavares CA; Rassi CH; Fahel MG; Wajchenberg BL; Rochitte CE; Lerario AC
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1577-85. PubMed ID: 27432440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.
    Takahashi S; Shimada K; Miyauchi K; Miyazaki T; Sai E; Ogita M; Tsuboi S; Tamura H; Okazaki S; Shiozawa T; Ouchi S; Aikawa T; Kadoguchi T; Al Shahi H; Yoshihara T; Hiki M; Isoda K; Daida H
    Cardiovasc Diabetol; 2016 Oct; 15(1):145. PubMed ID: 27729086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
    Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into the Association between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: An Intravascular Optical Coherence Tomography Study.
    Wang J; Jia L; Li X; Jin S; Li X; Liu F; Shan C; Zhang Y; Yang Y
    Cardiovasc Ther; 2019; 2019():8563717. PubMed ID: 31772619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients.
    Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):339-49. PubMed ID: 19356580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study.
    Deng F; Li D; Lei L; Yang Q; Li Q; Wang H; Deng J; Zheng Q; Jiang W
    Cardiovasc Diabetol; 2021 Sep; 20(1):188. PubMed ID: 34526013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Plaque Rupture Within Nonculprit Fibroatheromas in Patients With Acute Coronary Syndromes: The PROSPECT Study.
    Zheng B; Mintz GS; McPherson JA; De Bruyne B; Farhat NZ; Marso SP; Serruys PW; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2015 Oct; 8(10):1180-1187. PubMed ID: 26481843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
    Cheng JM; Suoniemi M; Kardys I; Vihervaara T; de Boer SP; Akkerhuis KM; Sysi-Aho M; Ekroos K; Garcia-Garcia HM; Oemrawsingh RM; Regar E; Koenig W; Serruys PW; van Geuns RJ; Boersma E; Laaksonen R
    Atherosclerosis; 2015 Dec; 243(2):560-6. PubMed ID: 26523994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
    Kim MJ; Jung HS; Hwang-Bo Y; Cho SW; Jang HC; Kim SY; Park KS
    Acta Diabetol; 2013 Aug; 50(4):505-10. PubMed ID: 21688018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study.
    Du R; Zhang RY; Lu L; Shen Y; Pu LJ; Zhu ZB; Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
    Cardiovasc Diabetol; 2018 Nov; 17(1):149. PubMed ID: 30482197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
    Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
    Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events.
    Migała M; Chałubińska-Fendler J; Zielińska M
    Rev Diabet Stud; 2022 Jun; 18(2):68-75. PubMed ID: 35831937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and intravascular ultrasound findings of culprit lesions in elderly patients with acute coronary syndrome.
    Ogura Y; Tsujita K; Shimomura H; Yamanaga K; Komura N; Miyazaki T; Ishii M; Tabata N; Akasaka T; Arima Y; Sakamoto K; Kojima S; Nakamura S; Kaikita K; Hokimoto S; Ogawa H
    Heart Vessels; 2016 Mar; 31(3):341-50. PubMed ID: 25523892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.